Hyperfine Inc (NASDAQ:HYPR) — Market Cap & Net Worth
Market Cap & Net Worth: Hyperfine Inc (HYPR)
Hyperfine Inc (NASDAQ:HYPR) has a market capitalization of $78.12 Million ($78.12 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20069 globally and #4517 in its home market, demonstrating a -1.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hyperfine Inc's stock price $0.94 by its total outstanding shares 83464909 (83.46 Million). Review Hyperfine Inc balance sheet liabilities to assess the company's total debt and financial obligations.
Hyperfine Inc Market Cap History: 2021 to 2026
Hyperfine Inc's market capitalization history from 2021 to 2026. Data shows change from $605.12 Million to $78.12 Million (-34.96% CAGR).
Index Memberships
Hyperfine Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #569 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1940 of 3165 |
Weight: Hyperfine Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Hyperfine Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hyperfine Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.03x
Hyperfine Inc's market cap is 6.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $605.12 Million | $1.50 Million | -$64.83 Million | 404.49x | N/A |
| 2022 | $70.11 Million | $6.81 Million | -$73.16 Million | 10.29x | N/A |
| 2023 | $93.48 Million | $11.03 Million | -$44.24 Million | 8.47x | N/A |
| 2024 | $73.45 Million | $12.89 Million | -$40.72 Million | 5.70x | N/A |
| 2025 | $81.74 Million | $13.56 Million | -$35.57 Million | 6.03x | N/A |
Competitor Companies of HYPR by Market Capitalization
Companies near Hyperfine Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Hyperfine Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Hyperfine Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Hyperfine Inc's market cap moved from $605.12 Million to $ 78.12 Million, with a yearly change of -34.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $78.12 Million | -4.42% |
| 2025 | $81.74 Million | +11.28% |
| 2024 | $73.45 Million | -21.43% |
| 2023 | $93.48 Million | +33.33% |
| 2022 | $70.11 Million | -88.41% |
| 2021 | $605.12 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Hyperfine Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $78.12 Million USD |
| MoneyControl | $78.12 Million USD |
| MarketWatch | $78.12 Million USD |
| marketcap.company | $78.12 Million USD |
| Reuters | $78.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hyperfine Inc
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture arc… Read more